Reduction of depression-like behavior in rat model induced by ShRNA targeting norepinephrine transporter in locus coeruleus

[1]  David Benrimoh,et al.  A systematic meta-review of predictors of antidepressant treatment outcome in major depressive disorder. , 2019, Journal of affective disorders.

[2]  Dan J Stein,et al.  Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2019, The Lancet Neurology.

[3]  K. Seki,et al.  Molecular mechanism of noradrenaline during the stress-induced major depressive disorder , 2018, Neural regeneration research.

[4]  J. Ioannidis,et al.  Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis , 2018, The Lancet.

[5]  M. Weger,et al.  High anxiety trait: A vulnerable phenotype for stress-induced depression , 2018, Neuroscience & Biobehavioral Reviews.

[6]  Dan J Stein,et al.  Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.

[7]  Mengjie Xu,et al.  Antidepressant-like effects and cognitive enhancement of Schisandra chinensis in chronic unpredictable mild stress mice and its related mechanism , 2017, Scientific Reports.

[8]  T. Bek,et al.  Suppression of choroidal neovascularization in mice by subretinal delivery of multigenic lentiviral vectors encoding anti-angiogenic microRNAs. , 2017, Human gene therapy methods.

[9]  P. Grandi,et al.  Viral vectors for therapy of neurologic diseases , 2017, Neuropharmacology.

[10]  Fang Pan,et al.  The Effects of High-fat-diet Combined with Chronic Unpredictable Mild Stress on Depression-like Behavior and Leptin/LepRb in Male Rats , 2016, Scientific Reports.

[11]  N. Jasnić,et al.  Melatonin mediated antidepressant-like effect in the hippocampus of chronic stress-induced depression rats: Regulating vesicular monoamine transporter 2 and monoamine oxidase A levels , 2016, European Neuropsychopharmacology.

[12]  P. Willner,et al.  The chronic mild stress (CMS) model of depression: History, evaluation and usage , 2016, Neurobiology of Stress.

[13]  P. Rancoita,et al.  Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial , 2016, The Lancet.

[14]  J. Kong,et al.  Combined use of spatial restraint stress and middle cerebral artery occlusion is a novel model of post-stroke depression in mice , 2015, Scientific Reports.

[15]  Yu Pan,et al.  Association between polymorphism of the norepinephrine transporter gene rs2242446 and rs5669 loci and depression disorders. , 2015, International journal of clinical and experimental medicine.

[16]  H. Malkki.  Alzheimer disease: NGF gene therapy activates neurons in the AD patient brain , 2015, Nature Reviews Neurology.

[17]  H. Cai,et al.  Fish oil supplementation alleviates depressant-like behaviors and modulates lipid profiles in rats exposed to chronic unpredictable mild stress , 2015, BMC Complementary and Alternative Medicine.

[18]  G. O’Keeffe,et al.  Viral vector delivery of neurotrophic factors for Parkinson's disease therapy , 2015, Expert Reviews in Molecular Medicine.

[19]  M. Berk,et al.  Effects of Persisting Emotional Impact from Child Abuse and Norepinephrine Transporter Genetic Variation on Antidepressant Efficacy in Major Depression: A Pilot Study , 2015, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

[20]  S. Kwon,et al.  Metabolomic identification of biochemical changes induced by fluoxetine and imipramine in a chronic mild stress mouse model of depression , 2015, Scientific Reports.

[21]  N. Déglon,et al.  [Gene silencing approaches for the treatment of Huntington's disease]. , 2015, Medecine sciences : M/S.

[22]  R. Lu,et al.  SLC6A2 variants may predict remission from major depression after venlafaxine treatment in Han Chinese population. , 2015, Journal of psychiatric research.

[23]  M. Kuśmider,et al.  Norepinephrine transporter knock-out alters expression of the genes connected with antidepressant drugs action , 2015, Brain Research.

[24]  A. Bemelmans,et al.  Gene therapy of the central nervous system: general considerations on viral vectors for gene transfer into the brain. , 2014, Revue neurologique.

[25]  Hidehiko Takahashi,et al.  Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[¹⁸F]FMeNER-D₂. , 2014, The international journal of neuropsychopharmacology.

[26]  R. Barker,et al.  Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial , 2014, The Lancet.

[27]  H. Su,et al.  Association between norepinephrine transporter T-182C polymorphism and major depressive disorder: A meta-analysis , 2014, Neuroscience Letters.

[28]  J. Shirey-Rice,et al.  Norepinephrine transporter heterozygous knockout mice exhibit altered transport and behavior , 2013, Genes, brain, and behavior.

[29]  M. Lindskog,et al.  Hippocampal and prefrontal dopamine D1/5 receptor involvement in the memory-enhancing effect of reboxetine. , 2013, The international journal of neuropsychopharmacology.

[30]  Hui Ma,et al.  Association between major depressive disorder and the norepinephrine transporter polymorphisms T-182C and G1287A: a meta-analysis. , 2013, Journal of affective disorders.

[31]  P. Blier,et al.  Monoamine neurocircuitry in depression and strategies for new treatments , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[32]  J. Foster,et al.  SLC6 transporters: structure, function, regulation, disease association and therapeutics. , 2013, Molecular aspects of medicine.

[33]  A. Harkin,et al.  Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism , 2013, Psychopharmacology.

[34]  J. Zhang,et al.  Noradrenergic innervation of pyramidal cells in the rat basolateral amygdala , 2013, Neuroscience.

[35]  D. Slattery,et al.  Using the rat forced swim test to assess antidepressant-like activity in rodents , 2012, Nature Protocols.

[36]  A. Altamura,et al.  The Noradrenergic Action in Antidepressant Treatments: Pharmacological and Clinical Aspects , 2011, CNS neuroscience & therapeutics.

[37]  R. Kao,et al.  Transcription factor Phox2 upregulates expression of norepinephrine transporter and dopamine β-hydroxylase in adult rat brains , 2011, Neuroscience.

[38]  M. Briley,et al.  The importance of norepinephrine in depression , 2011, Neuropsychiatric disease and treatment.

[39]  C. Sheridan,et al.  Gene therapy finds its niche , 2011, Nature Biotechnology.

[40]  M. Flajolet,et al.  Reversal of Depressed Behaviors in Mice by p11 Gene Therapy in the Nucleus Accumbens , 2010, Science Translational Medicine.

[41]  E. Carboni,et al.  Prenatal restraint stress: an in vivo microdialysis study on catecholamine release in the rat prefrontal cortex , 2010, Neuroscience.

[42]  K. Itoi,et al.  The Brainstem Noradrenergic Systems in Stress, Anxiety and Depression , 2010, Journal of neuroendocrinology.

[43]  Eduardo E. Benarroch,et al.  The locus ceruleus norepinephrine system , 2009, Neurology.

[44]  Heinz Bönisch,et al.  Knockout of the norepinephrine transporter and pharmacologically diverse antidepressants prevent behavioral and brain neurotrophin alterations in two chronic stress models of depression , 2009, Journal of neurochemistry.

[45]  A. Schambach,et al.  Clinical application of lentiviral vectors - concepts and practice. , 2008, Current gene therapy.

[46]  D. Murphy,et al.  Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions , 2008, Behavioural pharmacology.

[47]  R. Shelton,et al.  Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer Agents , 2007, Biological Psychiatry.

[48]  D. Kupfer,et al.  Acute and Longer- Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report , 2006 .

[49]  B. Lebowitz,et al.  Medication augmentation after the failure of SSRIs for depression. , 2006, The New England journal of medicine.

[50]  L. Lima,et al.  Noradrenaline transporter and its turnover rate are decreased in blood lymphocytes of patients with major depression , 2005, Journal of Neuroimmunology.

[51]  B. Mausbach,et al.  Depressive Symptoms Predict Norepinephrine Response to a Psychological Stressor Task in Alzheimer’s Caregivers , 2005, Psychosomatic medicine.

[52]  Michael J. Terry,et al.  Lentiviral Gene Therapy With Platelet-Derived Growth Factor B Sustains Accelerated Healing of Diabetic Wounds Over Time , 2005, Annals of plastic surgery.

[53]  E. Galun,et al.  Prolonged transgene expression in murine salivary glands following non-primate lentiviral vector transduction. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[54]  Marc G Caron,et al.  Uptake and Release of Norepinephrine by Serotonergic Terminals in Norepinephrine Transporter Knock-Out Mice: Implications for the Action of Selective Serotonin Reuptake Inhibitors , 2004, The Journal of Neuroscience.

[55]  D. Morilak,et al.  Regulation of the norepinephrine transporter by chronic administration of antidepressants , 2004, Biological Psychiatry.

[56]  C. Berridge,et al.  The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes , 2003, Brain Research Reviews.

[57]  A. Kingsman,et al.  Multicistronic Lentiviral Vector-Mediated Striatal Gene Transfer of Aromatic l-Amino Acid Decarboxylase, Tyrosine Hydroxylase, and GTP Cyclohydrolase I Induces Sustained Transgene Expression, Dopamine Production, and Functional Improvement in a Rat Model of Parkinson's Disease. , 2002, The Journal of Neuroscience.

[58]  M. Raichle,et al.  Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism , 2002, European Neuropsychopharmacology.

[59]  M. Barrot,et al.  Neurobiology of Depression , 2002, Neuron.

[60]  R. Wise,et al.  Dopamine Uptake through the Norepinephrine Transporter in Brain Regions with Low Levels of the Dopamine Transporter: Evidence from Knock-Out Mouse Lines , 2002, The Journal of Neuroscience.

[61]  T. Reader,et al.  Effects of chronic antidepressant treatments on 5-HT and NA transporters in rat brain: an autoradiographic study , 2001, Neurochemistry International.

[62]  C. Baird.  The pilot study. , 2000, Orthopedic nursing.

[63]  H. Bönisch,et al.  Comparison of the pharmacological properties of cloned rat, human, and bovine norepinephrine transporters. , 1999, The Journal of pharmacology and experimental therapeutics.

[64]  N. Hiroi,et al.  Regulation of cocaine reward by CREB. , 1998, Science.

[65]  Martin H. Teicher,et al.  Plasma norepinephrine and 3-methoxy-4-hydroxyphenylglycol concentrations and severity of depression in combat posttraumatic stress disorder and major depressive disorder , 1998, Biological Psychiatry.

[66]  F. Bloom,et al.  Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. , 1983, Physiological reviews.

[67]  Xinmei Tan,et al.  Carbapenems vs alternative antibiotics for the treatment of complicated urinary tract infection , 2020, Medicine.

[68]  T. Bek,et al.  Suppression of Choroidal Neovascularization in Mice by Subretinal Delivery of Multigenic Lentiviral Vectors Encoding Anti-Angiogenic MicroRNAs. , 2017, Human gene therapy methods.

[69]  G. Meister,et al.  siRNA design principles and off-target effects. , 2013, Methods in molecular biology.

[70]  M. Dimatteo,et al.  A Meta-Analysis , 2009 .

[71]  D. Nutt.  Relationship of neurotransmitters to the symptoms of major depressive disorder. , 2008, The Journal of clinical psychiatry.

[72]  D. Nutt.  The role of dopamine and norepinephrine in depression and antidepressant treatment. , 2006, The Journal of clinical psychiatry.

[73]  P. Willner,et al.  Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant , 2004, Psychopharmacology.

[74]  R. Neve,et al.  Viral-mediated gene transfer to study the behavioral correlates of CREB function in the nucleus accumbens of rats. , 2003, Methods in molecular medicine.

[75]  W. Tse,et al.  Difference in serotonergic and noradrenergic regulation of human social behaviours , 2001, Psychopharmacology.